SAN DIEGO, CA / ACCESS Newswire / October 15, 2025 / Just Just over six months after launch, Measured Risk Portfolios is ...

The Karnataka High Court on Monday (September 1) dismissed a plea by residents of Chikkajala Village seeking a direction to Bangalore Metro Rail Corporation Limited (BMRCL) to ensure that a metro ...

Gilman Hill acquired 235,475 shares of Millrose Properties for an estimated $7.9 million in the third quarter. The transaction represents 1.2% of Gilman Hill’s 13F reportable assets under management ...

Natco Pharma has secured yet another favourable ruling against a drug innovator, allowing it to sell a generic version of a ...

The division bench upheld the single-judge bench’s findings, which cited public interest in ensuring affordable access to SMA ...

REITs in 2025 are showing smarter capital moves, issuing equity at premiums, buying back undervalued shares, and cheap debt.

NATCO Pharma has won a landmark legal battle to launch a generic version of Risdiplam, a drug for Spinal Muscular Atrophy ...

Natco Pharma launches generic SMA drug at ₹15,900, following court ruling against Roche's unaffordable pricing.

Villagers from wards 5 and 7 in Insiza South have joined forces with local leaders and government stakeholders to grade the ...

The smart TV segment is crowded, where premium features often come with exorbitant price tags. However, Xiaomi has been a long-term disruptor by offering flagship features at a reasonable price. Here ...

The shares of the company have jumped more than 8% in the past six months, but have dropped nearly 40% in 2025 so far.